New monthly pill shows potential as pre-exposure prophylaxis HIV drug candidate
A new HIV antiretroviral shows promise as a long-acting, oral prophylactic agent, according to a new study by Izzat Raheem,…
A new HIV antiretroviral shows promise as a long-acting, oral prophylactic agent, according to a new study by Izzat Raheem,…
Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system…
Alzheimer’s disease (AD) currently afflicts nearly seven million people in the U.S. With this number expected to grow to nearly…
Since it was identified in 1984 as the cause of Acquired Immune Deficiency Syndrome (AIDS), the human immunodeficiency virus (HIV)…
Mpox patients treated with tecovirimat, an antiviral drug widely used since last summer’s outbreak, had similar outcomes regardless of HIV…
Failing to address the psychological trauma experienced by many older people living with HIV/AIDS will make it difficult, if not…
Commonly used antiretroviral drugs used to treat HIV and hepatitis B reduce immune cells’ energy production FINDINGS New UCLA-led research…
Both cervical and anal cancer are caused by human papillomavirus. Both diseases also share a common precursor: abnormal cells known…
Teams at the Institut Pasteur, CNRS, Vaccine Research Institute (VRI) and Université de Paris have discovered a new function of…
It’s long been known that people living with HIV experience a loss of white matter in their brains. As opposed…
In the 40-some years since the beginning of the HIV/AIDS epidemic, scientists have learned a lot about the virus, the…